Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Neoadjuvant Pemetrexed Disodium and Cisplatin Followed by Surgery and Radiation Therapy in Treating Patients With Pleural Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | July 1, 2003 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00072397 |
| Study Type: | Interventional |
| Intervention: | Drug: cisplatin|Drug: pemetrexed disodium|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Radiation: radiation therapy |
| Study Design: | Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Memorial Sloan-Kettering Cancer Center|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 77 |
| Funded By: | Other|NIH |
| First Received: | November 4, 2003 |
| End Date: | |
| Last Updated: | December 16, 2009 |
| Last Verified: | December 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
